drugset / Trial / NCT07236788
Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.
RandomizedParallel-groupSingle-blindTreatment
Summary
This study aimed to explore the effects of preoperative intravenous isomaltose iron supplementation versus placebo on postoperative Hb improvement, prevention of postoperative anemia, and improvement in quality of life in patients undergoing bariatric surgery.
Timeline
- Start
- 2025-03-01
- Primary completion
- 2026-12-30
- Completion
- 2027-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iron isomaltoside 1000 | Unknown | 20 mg/kg | Intravenous |
| Subject | Iron isomaltoside 1000 | Unknown | 500 mg | Intravenous |
| Subject | Iron isomaltoside 1000 | Unknown | 1000 mg | Intravenous |
| Subject | Iron isomaltoside 1000 | Unknown | 1500 mg | Intravenous |
| Subject | Iron isomaltoside 1000 | Unknown | 2000 mg | Intravenous |